- Home
- Signaling Pathways
- Others
- Others
- Risedronate Sodium
Risedronate Sodium
Catalog No.
A5293
FPP synthase inhibitor
Featured Products
Orally active biphosphonate that inhibits farnesyl diphosphate (FPP) synthase. Exhibits antiproliferative and proapoptotic activity in numerous tumor cell lines and inhibits osteoclast-mediated bone reabsorption in vivo.
Physical Appearance | A solid |
Storage | Store at -20°C |
M.Wt | 305.09 |
Cas No. | 115436-72-1 |
Formula | C7H10NNaO7P2 |
Solubility | insoluble in EtOH; insoluble in DMSO; ≥10.17 mg/mL in H2O with gentle warming |
Chemical Name | sodium;hydroxy-(1-hydroxy-1-phosphono-2-pyridin-3-ylethyl)phosphinate |
SDF | Download SDF |
Canonical SMILES | C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)[O-].[Na+] |
Shipping Condition | Small Molecules with Blue Ice, Modified Nucleotides with Dry Ice. |
General tips | We do not recommend long-term storage for the solution, please use it up soon. |
Quality Control & MSDS
- View current batch:
-
Purity = 98.00%
- COA (Certificate Of Analysis)
- MSDS (Material Safety Data Sheet)
- Datasheet